306 related articles for article (PubMed ID: 19661316)
1. SPARC is expressed in human uveal melanoma and its abrogation reduces tumor cell proliferation.
Maloney SC; Marshall JC; Antecka E; Orellana ME; Fernandes BF; Martins C; Castiglione E; DI Cesare S; Logan P; Burnier MN
Anticancer Res; 2009 Aug; 29(8):3059-64. PubMed ID: 19661316
[TBL] [Abstract][Full Text] [Related]
2. Expression of nm23-H1 in uveal melanoma.
Bakalian S; Marshall JC; Faingold D; Logan P; Antecka E; Burnier MN
Melanoma Res; 2007 Oct; 17(5):284-90. PubMed ID: 17885583
[TBL] [Abstract][Full Text] [Related]
3. Bone morphogenetic protein 7 inhibits tumor growth of human uveal melanoma in vivo.
Notting I; Buijs J; Mintardjo R; van der Horst G; Vukicevic S; Lowik C; Schalij-Delfos N; Keunen J; van der Pluijm G
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4882-9. PubMed ID: 17962434
[TBL] [Abstract][Full Text] [Related]
4. Characterizing the involvement of the nuclear factor-kappa B (NF kappa B) transcription factor in uveal melanoma.
Dror R; Lederman M; Umezawa K; Barak V; Pe'er J; Chowers I
Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):1811-6. PubMed ID: 19892878
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of chemokine receptors on uveal melanoma cells and their metastases.
Li H; Alizadeh H; Niederkorn JY
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):636-43. PubMed ID: 18235009
[TBL] [Abstract][Full Text] [Related]
6. Expression of the metastasis suppressor gene KISS1 in uveal melanoma.
Martins CM; Fernandes BF; Antecka E; Di Cesare S; Mansure JJ; Marshall JC; Burnier MN
Eye (Lond); 2008 May; 22(5):707-11. PubMed ID: 18219339
[TBL] [Abstract][Full Text] [Related]
7. Silencing of secreted protein acidic and rich in cysteine inhibits the growth of human melanoma cells with G arrest induction.
Horie K; Tsuchihara M; Nakatsura T
Cancer Sci; 2010 Apr; 101(4):913-9. PubMed ID: 20100207
[TBL] [Abstract][Full Text] [Related]
8. Angiogenic profile of uveal melanoma.
Notting IC; Missotten GS; Sijmons B; Boonman ZF; Keunen JE; van der Pluijm G
Curr Eye Res; 2006 Sep; 31(9):775-85. PubMed ID: 16966150
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.
Yan D; Zhou X; Chen X; Hu DN; Dong XD; Wang J; Lu F; Tu L; Qu J
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1559-65. PubMed ID: 19029026
[TBL] [Abstract][Full Text] [Related]
10. The p53/p21Cip1/ Waf1 pathway mediates the effects of SPARC on melanoma cell cycle progression.
Fenouille N; Robert G; Tichet M; Puissant A; Dufies M; Rocchi S; Ortonne JP; Deckert M; Ballotti R; Tartare-Deckert S
Pigment Cell Melanoma Res; 2011 Feb; 24(1):219-32. PubMed ID: 20955243
[TBL] [Abstract][Full Text] [Related]
11. Inhibitor of apoptosis proteins gene expression and its correlation with prognostic factors in primary and metastatic uveal melanoma.
Lederman M; Meir T; Zeschnigk M; Pe'er J; Chowers I
Curr Eye Res; 2008 Oct; 33(10):876-84. PubMed ID: 18853322
[TBL] [Abstract][Full Text] [Related]
12. Small interfering RNA inhibition of SPARC attenuates the profibrotic effect of transforming growth factor beta1 in cultured normal human fibroblasts.
Zhou X; Tan FK; Guo X; Wallis D; Milewicz DM; Xue S; Arnett FC
Arthritis Rheum; 2005 Jan; 52(1):257-61. PubMed ID: 15641096
[TBL] [Abstract][Full Text] [Related]
13. Status of RASSF1A in uveal melanocytes and melanoma cells.
Calipel A; Abonnet V; Nicole O; Mascarelli F; Coupland SE; Damato B; Mouriaux F
Mol Cancer Res; 2011 Sep; 9(9):1187-98. PubMed ID: 21788308
[TBL] [Abstract][Full Text] [Related]
14. Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type.
Paraoan L; Gray D; Hiscott P; Ebrahimi B; Damato B; Grierson I
Exp Eye Res; 2006 Oct; 83(4):911-9. PubMed ID: 16784742
[TBL] [Abstract][Full Text] [Related]
15. Cripto-1 expression in uveal melanoma: an immunohistochemical study.
Mallikarjuna K; Vaijayanthi P; Krishnakumar S
Exp Eye Res; 2007 Jun; 84(6):1060-6. PubMed ID: 17412323
[TBL] [Abstract][Full Text] [Related]
16. The differential expression of SPARC in esophageal squamous cell carcinoma.
Che Y; Luo A; Wang H; Qi J; Guo J; Liu Z
Int J Mol Med; 2006 Jun; 17(6):1027-33. PubMed ID: 16685412
[TBL] [Abstract][Full Text] [Related]
17. The role of RASSF1A in uveal melanoma.
Dratviman-Storobinsky O; Cohen Y; Frenkel S; Merhavi-Shoham E; El SD; Binkovsky N; Pe'er J; Goldenberg-Cohen N
Invest Ophthalmol Vis Sci; 2012 Oct; 53(6):2611-9. PubMed ID: 22447862
[TBL] [Abstract][Full Text] [Related]
18. Highly sensitive detection of melanoma at an early stage based on the increased serum secreted protein acidic and rich in cysteine and glypican-3 levels.
Ikuta Y; Nakatsura T; Kageshita T; Fukushima S; Ito S; Wakamatsu K; Baba H; Nishimura Y
Clin Cancer Res; 2005 Nov; 11(22):8079-88. PubMed ID: 16299239
[TBL] [Abstract][Full Text] [Related]
19. p54nrb is a new regulator of progression of malignant melanoma.
Schiffner S; Zimara N; Schmid R; Bosserhoff AK
Carcinogenesis; 2011 Aug; 32(8):1176-82. PubMed ID: 21642354
[TBL] [Abstract][Full Text] [Related]
20. Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma.
Chen X; Wang J; Shen H; Lu J; Li C; Hu DN; Dong XD; Yan D; Tu L
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1193-9. PubMed ID: 21051724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]